Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Entacapone improves the pharmacokinetic and therapeutic response of controlled release levodopa/carbidopa in Parkinson’s patients

    The aim of this trial was to evaluate the effects of the COMT inhibitor entacapone on both the pharmacokinetic profile and clinical efficacy of controlled release levodopa in Parkinson’s disease (PD) patients....

    F. Stocchi, L. Barbato, G. Nordera, A. Bolner in Journal of Neural Transmission (2004)

  2. No Access

    Article

    Increased plasma bilirubin in Parkinson patients on L-dopa: evidence against the free radical hypothesis?

    Oxidative damage by free radicals may contribute to the etiology of Parkinson's disease (PD), and increased oxidative stress in the nigral cells of PD patients may occur following L-dopa treatment, prompting s...

    Dr. G. Scigliano, F. Girotti, P. Soliveri in The Italian Journal of Neurological Scienc… (1997)

  3. No Access

    Article

    Survival in multiple system atrophy: a study of prognostic factors in 59 cases

    The various clinical features of multiple system atrophy (MSA) make the diagnosis of the disease difficult, especially in its early stages, when signs of differentiated neuroanatomical system involvement have ...

    D. Testa, G. Filippini, M. Farinotti, E. Palazzini, T. Caraceni in Journal of Neurology (1996)

  4. No Access

    Article

    Progression of motor and cognitive impairment in Parkinson's disease

    We performed a longitudinal study (mean follow-up 86.7 months) to evaluate motor and mental deterioration in patients with Parkinson's disease. Of the original 91 patients, only 61 could be re-examined 7 years...

    E. Palazzini, P. Soliveri, G. Filippini, V. Fetoni, B. Zappacosta in Journal of Neurology (1995)

  5. No Access

    Article

    Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients

    Psychiatric symptoms were investigated and compared in 95 patients with Alzheimer type dementia (DAT) and in 39 patients with Parkinson's disease with dementia (PD-D). The diagnosis of the dementia and psychia...

    P. Soliveri, M. B. Zappacesta, L. Austoni in The Italian Journal of Neurological Scienc… (1994)

  6. No Access

    Article

    Spasmodic dystonic laterocollis in familial cerebellar ataxia

    The case of a woman affected by familial ataxia who developed marked spasmodic laterocollis is described. As this appears to be an uncommon association, it is worth reporting one more case.

    Dr. F. Carella, C. Ciano, M. Padolfo in The Italian Journal of Neurological Scienc… (1994)

  7. No Access

    Article

    Botulinum toxin treatment in patients with focal dystonia and hemifacial spasm. A multicenter study of the Italian Movement Disorder Group

    In six Centers belonging to the Italian Movement Disorder Study Group, the efficacy of botulinum toxin treatment was evaluated in an open collaborative study in 251 patients with focal dystonia and hemifacial ...

    Dr. A. Berardelli, A. Formica, B. Mercuri in The Italian Journal of Neurological Scienc… (1993)

  8. No Access

    Article

    Hemichorea due to a cavernous angioma of the caudate. Case report of an aged patient

    A 75 year old man presented left hemichorea due to a cavernous angioma of the head of the contralateral caudate. Cavernous angiomas of the basal ganglia are an infrequent cause of hemichorea especially in olde...

    Dr. F. Carella, T. Caraceni, F. Girotti in The Italian Journal of Neurological Sciences (1992)

  9. No Access

    Article

    Book reviews

    G. Gainotti, G. Filippini, T. Caraceni in The Italian Journal of Neurological Scienc… (1991)

  10. No Access

    Chapter

    Course of Motor and Cognitive Impairment in Huntington’s Chorea

    Motor impairment, mental decay and psychopathological abnormalities all contribute to functional disability in Huntington’s Chorea (HC) (1–3) though Mayeux et al (4) concluded that a major role is played by in...

    F. Girotti, D. Oliva, V. Fetoni, D. Testa, P. Soliveri in The Basal Ganglia III (1991)

  11. No Access

    Chapter and Conference Paper

    Adrenal Medulla Autograft in Caudate Nucleus as Treatment for Parkinson Disease

    The personal experience of four Parkinson’s disease patients operated on with adrenal medulla autograft in the caudate nucleus is reported. Results on long term, possible only in two patients, are moderately f...

    G. Broggi, F. Pluchino, L. Gennari in Advances in Stereotactic and Functional Ne… (1991)

  12. No Access

    Chapter

    Treatment of Motor Fluctuations in Parkinson’s Disease: Controlled Release Preparations

    The fundamental problem in the treatment of Parkinson’s disease is the appearance of motor fluctuations after long-term drug therapy (long-term L-dopa treatment syndrome, LTS, Marsden and Parkes, 1976). The cl...

    T. Caraceni, G. Geminiani, S. Genitrini, P. Giovannini, F. Girotti in The Basal Ganglia III (1991)

  13. No Access

    Article

    Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis

    Thirty-two patients affected by amyotrophic lateral sclerosis (ALS) were included in a controlled, open therapeutic trial with branched chain amino acids (BCAA). Patients with bulbar muscle involvement were ev...

    D. Testa, T. Caraceni, V. Fetoni in Journal of Neurology (1989)

  14. No Access

    Article

    Deprenyl in Parkinson disease: personal experience

    The aim of this study was to evaluate the therapeutic activity of Deprenyl in patients with Parkinson disease already being treated with L-Dopa+PDI. 15 selected patients were allocated to two groups according ...

    Dr. P. Giovannini, M. P. Grassi in The Italian Journal of Neurological Scienc… (1985)

  15. No Access

    Chapter

    Neuroendocrine Control of Pituitary Function in Extrapiramidal Disorders

    The purpose of this study was to reconsider the functional status of the hypothalamus-pituitary axis in diseases of the extrapyramidal system. The theme of the paper is behavior of the secretion of growth horm...

    T. Caraceni, P. Giovannini, E. Parati in Biological Psychiatry, Higher Nervous Acti… (1985)

  16. No Access

    Article

    Book reviews

    F. Corridori, T. Caraceni, A. Nespolo in The Italian Journal of Neurological Scienc… (1984)

  17. No Access

    Article

    Bromocriptine — lisuride cross tolerance

    P. Giovannini, G. Scigliano, M. P. Grassi in The Italian Journal of Neurological Scienc… (1983)

  18. No Access

    Article

    Idiopathic dystonia: Neuropharmacological study

    A total of 15 patients affected by idiopathic dystonia (7 with generalized and 8 with focal or segmental dystonia) were subjected to therapy with bromocriptine at low doses, pimozide and trihexyphenidyl. The s...

    F. Girotti, G. Scigliano, N. Nardocci, L. Angelini, G. Broggi in Journal of Neurology (1982)

  19. No Access

    Article

    Book reviews

    A. Albanese, T. Caraceni, A. Passerini in The Italian Journal of Neurological Scienc… (1982)

  20. No Access

    Article

    Book reviews

    S. Di Donato, T. Caraceni in The Italian Journal of Neurological Sciences (1981)

previous disabled Page of 2